CRANBURY, N.J.--(BUSINESS WIRE)--Healthcare Research Analytics (HRA®), a consultative healthcare market research practice, will present the “Physician and Institution Preparedness for CAR-T Therapy” webinar on Feb. 28 at 1 p.m. EST, based on original research from HRA®, announced Steve Ennen, chief digital strategy officer at Michael J. Hennessy Associates, Inc., parent company of HRA®.
“We are thrilled to present this informational webinar that will touch upon some of the most common concerns faced by physicians, oncologists and cancer centers regarding CAR-T cell therapy,” said Ennen. “It’s exciting to see the rise of new treatments to fight cancer and it’s crucial for clinicians and institutions to gain a deep understanding about these treatments.”
The webinar will explore CAR-T cell therapy, a type of immunotherapy that channels the power of the immune system to fight cancer. Physician and institution awareness and challenges regarding developing CAR-T cell therapies such as Kymriah and Yescarta will also be discussed. This webinar’s goal is to establish actionable insights on how to establish CAR-T as a standard of treatment.
For more information and to register, visit https://www.hraresearch.com/webinars-and-analytics/physician-and-institution-preparedness-for-cart
HRA®, Healthcare Research & Analytics, is a consultative healthcare market research practice combining the power of MJH Associates and a team of highly experienced market research professionals who have a passion for uncovering insights for clients across the pharmaceutical, biotech and medical device markets. For more information, visit http://www.hraresearch.com.